Catalyst Wire Dossier Catalyst Wire Dossier

ASP7373

· UMN Pharma Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASP7373, covering 2017-09-29 to 2017-09-29. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Immune Response to the ASP7373 and Its Safety in Healthy Adult Volunteers [Phase 2]

See pricing